Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research, No. 1:2015cv02044 - Document 185 (S.D.N.Y. 2018)

Court Description: MEMORANDUM OPINION AND ORDER: Although the evidence supports a conclusion that Errant Gene's counsel failed to act in an objectively reasonable manner in determining whether diversity jurisdiction existed, it does not support a conclusion that they acted with subjective bad faith. Sanctions imposed sua sponte pursuant to Rule 11 are thus not warranted, and as further set forth in this order. (Signed by Judge Alison J. Nathan on 4/4/2018) (ap)